Fig. 7. A summary model linking inosine and immunotherapy responses.

The metabolic imbalance, especially inosine, is associated with immunotherapy responses in mice and humans. Inosine overcomes tumour-intrinsic resistance to immunotherapy by inhibiting UBA6 and increasing tumour immunogenicity in tumours with UBA6-high expression.